• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定与 COVID-19 患者死亡结局相关的自然杀伤细胞标志物。

Identification of natural killer markers associated with fatal outcome in COVID-19 patients.

机构信息

Sorbonne Université, Inserm, CNRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Hôpital Pitié-Salpêtrière, Paris, France.

Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Département d'Immunologie, Paris, France.

出版信息

Front Cell Infect Microbiol. 2023 Jun 5;13:1165756. doi: 10.3389/fcimb.2023.1165756. eCollection 2023.

DOI:10.3389/fcimb.2023.1165756
PMID:37342247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10277643/
Abstract

INTRODUCTION

Increasing evidence has shown that coronavirus disease 19 (COVID-19) severity is driven by a dysregulated immunological response. Previous studies have demonstrated that natural killer (NK) cell dysfunction underpins severe illness in COVID-19 patients, but have lacked an in-depth analysis of NK cell markers as a driver of death in the most critically ill patients.

METHODS

We enrolled 50 non-vaccinated hospitalized patients infected with the initial virus or the alpha variant of SARS-CoV-2 with moderate or severe illness, to evaluate phenotypic and functional features of NK cells.

RESULTS

Here, we show that, consistent with previous studies, evolution NK cells from COVID-19 patients are more activated, with the decreased activation of natural cytotoxicity receptors and impaired cytotoxicity and IFN-γ production, in association with disease regardless of the SARS-CoV-2 strain. Fatality was observed in 6 of 17 patients with severe disease; NK cells from all of these patients displayed a peculiar phenotype of an activated memory-like phenotype associated with massive TNF-α production.

DISCUSSION

These data suggest that fatal COVID-19 infection is driven by an uncoordinated inflammatory response in part mediated by a specific subset of activated NK cells.

摘要

简介

越来越多的证据表明,新型冠状病毒病 19(COVID-19)的严重程度是由免疫反应失调引起的。先前的研究表明,自然杀伤(NK)细胞功能障碍是 COVID-19 患者重病的基础,但缺乏对 NK 细胞标志物作为最危重患者死亡驱动因素的深入分析。

方法

我们招募了 50 名未接种疫苗的住院感染 SARS-CoV-2 初始病毒或阿尔法变异株的中度或重度疾病患者,以评估 NK 细胞的表型和功能特征。

结果

在这里,我们表明,与先前的研究一致,COVID-19 患者的 NK 细胞更具活性,自然细胞毒性受体的激活减少,细胞毒性和 IFN-γ产生受损,与疾病相关,而与 SARS-CoV-2 株无关。17 名重症患者中有 6 人死亡;所有这些患者的 NK 细胞均表现出一种独特的表型,即与大量 TNF-α产生相关的激活记忆样表型。

讨论

这些数据表明,致命性 COVID-19 感染是由部分由特定的激活 NK 细胞亚群介导的不协调的炎症反应驱动的。

相似文献

1
Identification of natural killer markers associated with fatal outcome in COVID-19 patients.鉴定与 COVID-19 患者死亡结局相关的自然杀伤细胞标志物。
Front Cell Infect Microbiol. 2023 Jun 5;13:1165756. doi: 10.3389/fcimb.2023.1165756. eCollection 2023.
2
Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.韩国住院COVID-19患者淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变异株的差异
J Korean Med Sci. 2025 Jul 28;40(29):e172. doi: 10.3346/jkms.2025.40.e172.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
5
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
6
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.自然杀伤细胞受体和配体与慢性感染接受 ART 抑制的患者中 HIV-1 持续存在的标志物相关。
Front Cell Infect Microbiol. 2022 Feb 10;12:757846. doi: 10.3389/fcimb.2022.757846. eCollection 2022.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.

引用本文的文献

1
Natural killer (NK) cells in bipolar disorders.双相情感障碍中的自然杀伤(NK)细胞。
Neurosci Appl. 2024 Apr 11;3:104066. doi: 10.1016/j.nsa.2024.104066. eCollection 2024.
2
Investigation of -21 M/T Dimorphism and Its Potential Role in COVID-19.-21 M/T 二态性及其在 COVID-19 中的潜在作用研究。
Int J Mol Sci. 2025 Jul 3;26(13):6419. doi: 10.3390/ijms26136419.
3
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease.细胞游离 NKG2D 配体水平升高可调节 NKG2D 表面表达并损害严重 COVID-19 疾病中的 NK 细胞功能。

本文引用的文献

1
Plasticity of natural killer cells in pregnant patients infected with SARS-CoV-2 and their neonates during childbirth.在分娩期间感染 SARS-CoV-2 的孕妇及其新生儿的自然杀伤细胞的可塑性。
Front Immunol. 2022 Jul 15;13:893450. doi: 10.3389/fimmu.2022.893450. eCollection 2022.
2
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.自然杀伤细胞在 SARS-CoV-2 感染中的作用:病理生理学及治疗意义。
Front Immunol. 2022 Jun 30;13:888248. doi: 10.3389/fimmu.2022.888248. eCollection 2022.
3
Natural killer cell exhaustion in SARS-CoV-2 infection.
Front Immunol. 2024 Feb 12;15:1273942. doi: 10.3389/fimmu.2024.1273942. eCollection 2024.
新型冠状病毒感染中的自然杀伤细胞耗竭。
Innate Immun. 2022 Aug;28(6):189-198. doi: 10.1177/17534259221077750. Epub 2022 Jun 22.
4
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection.COVID-19 肺部感染致死型中的记忆性 CD4+ T 细胞淋巴细胞血管炎。
Front Immunol. 2022 Apr 22;13:844727. doi: 10.3389/fimmu.2022.844727. eCollection 2022.
5
Targeting TNF-α for COVID-19: Recent Advanced and Controversies.针对 COVID-19 的 TNF-α 靶点:最新进展与争议。
Front Public Health. 2022 Feb 11;10:833967. doi: 10.3389/fpubh.2022.833967. eCollection 2022.
6
NK cell dysfunction in patients with COVID-19.新型冠状病毒肺炎患者的自然杀伤细胞功能障碍
Cell Mol Immunol. 2022 Feb;19(2):127-129. doi: 10.1038/s41423-021-00825-2. Epub 2022 Jan 13.
7
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.COVID-19 中 TGFβ 的过早反应限制了 NK 细胞的抗病毒功能。
Nature. 2021 Dec;600(7888):295-301. doi: 10.1038/s41586-021-04142-6. Epub 2021 Oct 25.
8
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.早期 IFN-α 特征和持续功能障碍是严重 COVID-19 中 NK 细胞的显著特征。
Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002. Epub 2021 Sep 4.
9
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.鉴定危重症 COVID-19 患者死亡结局的免疫相关因素。
PLoS Pathog. 2021 Sep 16;17(9):e1009804. doi: 10.1371/journal.ppat.1009804. eCollection 2021 Sep.
10
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.在新诊断的新冠患者的鼻咽样本中,新冠病毒德尔塔变异株的病毒载量高于贝塔变异株和既往变异株。
J Infect. 2021 Oct;83(4):e1-e3. doi: 10.1016/j.jinf.2021.08.027. Epub 2021 Aug 19.